SE1 2.53% 8.1¢ sensera limited

Ann: Organ-on-Chip A Growing MedTech Opportunity for Sensera, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 127 Posts.
    lightbulb Created with Sketch. 14
    Incredible for SE1 to move into this space, especially along side Harvard.

    Animal testing or petri dish testing has always had its flaws to mimic the human body. Organ-on-a-chip moulds made by SE1 help solve this problem moving forward.

    The likes of Abiomed, Harvard and Smartbow/Zoetis in the books of SE1....does not sound like a 28m mcap stock to me.

    https://emulatebio.com/

    https://wyss.harvard.edu/technology/human-organs-on-chips/
    Last edited by brosef: 05/06/18
 
watchlist Created with Sketch. Add SE1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.